Archived – Association Of Topamax* (topiramate) With Acute Myopia And Secondary Angle Closure Glaucoma

TOPAMAX (Topiramate) Recall Summary TOPAMAX (topiramate), a medication distributed across Canada, has been recalled due to its association with acute myopia (nearsightedness) and secondary angle closure glaucoma. These eye conditions can develop in patients taking this drug. This recall affects all Canadian consumers who have been prescribed or are using TOPAMAX.

Reason

Product safety

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2001-09-13

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/ac73d91f-ddd6-46f7-807f-e1e2c3ee651f